Stay updated on Pembrolizumab Combo Clinical Trial in Advanced NSCLC
Sign up to get notified when there's something new on the Pembrolizumab Combo Clinical Trial in Advanced NSCLC page.

Latest updates to the Pembrolizumab Combo Clinical Trial in Advanced NSCLC page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedFooter now shows Revision: v3.6.3, replacing the previous v3.6.2, indicating a page-level revision update.SummaryDifference0.0%

- Check19 days agoChange DetectedThe history now includes a new version entry on 2026-06-23 that adds Contacts/Locations and Study Status to the record, and notes a new revision (v3.6.2) while the prior v3.6.0 revision is removed.SummaryDifference0.2%

- Check26 days agoChange DetectedTwo new history entries were added for 2026-06-16 and 2026-06-12, indicating updates to Study Status and Contacts/Locations. Additionally, the 2026-05-18 entry was removed.SummaryDifference0.2%

- Check34 days agoChange DetectedNew links 'Check who can join' and 'Find Contact Information' were added, and the revision label updated from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check41 days agoChange DetectedThe page's revision tag has been updated from v3.5.4 to v3.5.5, indicating a minor update to the ClinicalTrials.gov interface.SummaryDifference0.0%

- Check55 days agoChange DetectedOn 2026-05-18, the history adds the Contacts/Locations and Study Status sections to the record, expanding the visible information about who to contact and the trial's current status. A prior entry dated 2026-03-16 is removed from the history.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab Combo Clinical Trial in Advanced NSCLC
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo Clinical Trial in Advanced NSCLC page.